ArticleBMC public health2026
Evaluation of a bridge-based suicide intervention programme: findings from a qualitative study with volunteers and professional staff.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuicide is a preventable, but complex public health issue. Around one-third of suicides take place in a public location. Easy access to means of self-harm in public spaces, such as bridges, increases risk. While physical modifications (e.g., barriers) are effective for means reduction, they are not always feasible to implement. Bridge Watch is a suicide prevention initiative that uses trained volunteers to patrol public spaces around bridges in the City of London. The volunteers aim to identify and engage with individuals in distress to reduce suicide incidents (attempts and suicide deaths).
methodsThis qualitative study explores the implementation barriers and facilitators, and the perceived effectiveness of Bridge Watch. We conducted 27 semi-structured interviews with professionals who have had some involvement with Bridge Watch (n = 8) and current Bridge Watch volunteers (n = 19). Data collection was supplemented by analysing 16 volunteer diary entries completed post-patrol. Data were analysed using framework analysis.
resultsVolunteers and professionals reported examples of how the Bridge Watch programme had identified and supported individuals in acute crises, as well as intervening with people who might otherwise have gone unnoticed. The programme was seen to provide a range of secondary public health impacts, including supporting and signposting for vulnerable individuals, and raising public awareness of suicide prevention. Emergency service staff suggested that Bridge Watch can help reduce pressure on services by de-escalating situations. Robust, relevant and frequent training which reflects the conditions of the Bridge Watch role is crucial for preparing volunteers. The Bridge Watch programme faces several operational challenges, including volunteer recruitment and capacity to provide 24-hour coverage. While positive relationships exist with statutory services (e.g., police), there is a need for improved awareness and stronger integration.
conclusionsBridge Watch appears to be a promising, acceptable, and valued suicide prevention strategy. It offers benefits through direct interventions and broader public health contributions. Its key strengths are its proactive, visible, immediate, human-centred approach and its ability to support statutory services. However, in the development of such interventions, consideration needs to be given to potential unintended consequences, including the risk of drawing attention to specific locations as sites of suicide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.